Business
Leveljump Healthcare Corp. Acquires Additional 2.3% of Real Time Medical; Exercises Right to Acquire Additional 1.5% of Shaw Lens and Shaw Vision; Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 17, 2021) - Leveljump Healthcare Corp. (TSXV: JUM...
About this update from Leveljump Healthcare Corp.
[{"type":"text","content":"Leveljump Healthcare Corp. Acquires Additional 2.3% of Real Time Medical; Exercises Right to Acquire Additional 1.5% of Shaw Lens and Shaw Vision; Provides Corporate UpdateToronto, Ontario--(Newsfile Corp. - December 17, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (\"Leveljump\" or the \"Company\"), a Canadian leader in B2B telehealth solutions, is pleased to announce that, subject to regulatory approval, it has agreed to acquire an additional 2.3% minority equity interest in Real Time Medical Inc. (\"RTM\"), a private Ontario company, in exchange for 392,875 units (a \"Unit\") of Leveljump. Each Unit will be issued at a price of $0.50 per Unit with each Unit being comprised of three (3) Leveljump common shares at a deemed price of $0.15 per share and one (1) share purchase warrant of Leveljump, each warrant entitling the holder to acquire one additional common share of Leveljump at a price of $0.35 per common share on or before December 31, 2023.Leveljump will now own a 16.9% interest in RTM.Closing of the RTM purchase is subject to the consent of the TSX Venture Exchange (the \"Exchange\"). For further information regarding the Company's interest in RTM, please see the Company's news release dated November 25, 2021.All securities issued will be subject to a hold period of four months and one day pursuant to applicable securities laws.Shaw CompaniesLeveljump has agreed to exercise its right of first refusal to purchase a further 1.5% minority interest in each of Shaw Lens Inc. and Shaw Vision Inc. for a total price of $15,000. The Company will be advised in approximately 30 days if it will receive the full allotment of the 1.5% interest or if other shareholders of the Shaw companies will also exercise their rights and if the shares will be pro-rated amongst all existing shareholders who make a claim to purchase the shares.If the Company receives the full allotment of the shares for sale it will then own approximately 25.3% in the Shaw companies.For further information regarding the Company's interest in Shaw Lens Inc. and Shaw Vision Inc., please see the Company's news release dated August 31, 2021.Management Purchase of SharesSubject to the consent of the Exchange and, where required, disinterested shareholder approval, both the CEO and CFO of the Company have agreed to convert an aggregate of $24...